The organizations will partner for a 90-day campaign to promote optometry awareness.

Duo commits to a second year working together after a year of achievements in addressing myopia management among ECPs.

Five recipients will receive funding to atttend this years ARVO meeting in Denver, Colorado.

Trial data finds that CSF-1 (pilocarpine hydrochloride 0.4%), a preservative-free ophthalmic solution, met both its primary and secondary endpoints.

New activator features a single-piece eye cup and translucent design that allows for more efficient and accurate positioning in the eye.

Investigators report a correlation between the risk of 5-letter visual acuity (VA) loss at 24 months for eyes with clinically significant diabetic macular edema (CSDME) and good VA initially treated and eyes that were initially observed in routine clinical practice.

A new survey commissioned by the Contact Lens Institute found that US eye care practitioners are failing to take advantage of the opportunity to discuss contact lens options with 2 out of 3 patients. Two virtual panel discussions on May 3 will analyze the data.

Lois Schoenbrun, CAE (ret.), FAAO, previously served as executive director of the American Academy of Optometry.

Gifted by philanthropist James Grosfeld, the money will fund the launching of a pioneering research initiative as one of the largest investments of resources in the United States.

Changes in three new positions took effect this month.

As part of its partnership, Shamir will provide insight and expertise for sales development, customer service, as well as research and development

A comprehensive analysis of the possible directions corporate optical practices might be headed in.

Michael Brown, OD, MHS-CL, FAAO shares what he wishes he knew before starting his career in optometry.

Study evaluated twice-daily administration of VUITY (pilocarpine HCI ophthalmic solution) 1.25% in adults with age-related blurry near Vision

Live from Vision Expo East in New York, a look at Tura's new line of glasses: Glemaud.

Elevatum was created as a phase 4, multicenter, open-label, single-arm trial to specifically study Vabysmo (faricimab-svoa) in these underrepresented populations.

Sunlight in the classroom can be a protective measure against the development of myopia, researchers have found.

The partnership is in support of the company's latest dry eye relief campaign and part of the launch for its leading global artificial tear drop brand.

Fully recovered COVID-19 patients have a higher prevalence for developing dry eye disease, researchers report.